Stephen Dreskin
Concepts (463)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peanut Hypersensitivity | 26 | 2023 | 199 | 6.820 |
Why?
| Immunoglobulin E | 40 | 2023 | 317 | 5.980 |
Why?
| Antigens, Plant | 22 | 2023 | 47 | 5.410 |
Why?
| Allergens | 23 | 2023 | 417 | 5.310 |
Why?
| 2S Albumins, Plant | 19 | 2023 | 25 | 5.220 |
Why?
| Arachis | 19 | 2023 | 147 | 4.350 |
Why?
| Glycoproteins | 12 | 2016 | 305 | 2.970 |
Why?
| Urticaria | 11 | 2018 | 50 | 2.660 |
Why?
| Epitopes | 8 | 2023 | 436 | 1.870 |
Why?
| Mast Cells | 13 | 2021 | 117 | 1.670 |
Why?
| Basophils | 14 | 2018 | 64 | 1.550 |
Why?
| Desensitization, Immunologic | 3 | 2019 | 117 | 1.080 |
Why?
| Benzoquinones | 4 | 2007 | 44 | 0.850 |
Why?
| Food Hypersensitivity | 3 | 2020 | 254 | 0.840 |
Why?
| Nuts | 2 | 2023 | 12 | 0.790 |
Why?
| Anti-Allergic Agents | 3 | 2018 | 41 | 0.730 |
Why?
| Receptors, IgE | 11 | 2003 | 40 | 0.720 |
Why?
| Omalizumab | 2 | 2018 | 46 | 0.710 |
Why?
| Seeds | 1 | 2020 | 76 | 0.710 |
Why?
| Plant Proteins | 6 | 2023 | 81 | 0.700 |
Why?
| Amino Acids | 1 | 2023 | 449 | 0.690 |
Why?
| Peptide Library | 2 | 2017 | 81 | 0.680 |
Why?
| Peptide Mapping | 1 | 2019 | 60 | 0.670 |
Why?
| Anaphylaxis | 3 | 2018 | 148 | 0.670 |
Why?
| Allergists | 1 | 2018 | 19 | 0.620 |
Why?
| Protein Conformation | 5 | 2022 | 811 | 0.620 |
Why?
| Immunoglobulin G | 7 | 2022 | 776 | 0.590 |
Why?
| Allergy and Immunology | 1 | 2018 | 53 | 0.590 |
Why?
| Plant Extracts | 3 | 2018 | 155 | 0.570 |
Why?
| Rhinitis, Allergic, Seasonal | 3 | 2008 | 32 | 0.570 |
Why?
| Bortezomib | 1 | 2016 | 41 | 0.550 |
Why?
| Anti-Inflammatory Agents | 4 | 2008 | 451 | 0.530 |
Why?
| Drug Hypersensitivity | 2 | 2013 | 85 | 0.520 |
Why?
| Interleukin-5 | 2 | 2008 | 30 | 0.510 |
Why?
| Amino Acid Sequence | 7 | 2023 | 1988 | 0.510 |
Why?
| Antibodies, Anti-Idiotypic | 2 | 2014 | 54 | 0.510 |
Why?
| Hypersensitivity, Immediate | 4 | 2013 | 46 | 0.490 |
Why?
| Proteome | 1 | 2018 | 339 | 0.480 |
Why?
| Humans | 69 | 2023 | 114925 | 0.470 |
Why?
| Models, Molecular | 2 | 2016 | 1379 | 0.470 |
Why?
| Animals | 33 | 2022 | 31837 | 0.460 |
Why?
| Peptides | 6 | 2023 | 848 | 0.460 |
Why?
| Cell Degranulation | 3 | 2014 | 39 | 0.430 |
Why?
| Cross Reactions | 4 | 2023 | 117 | 0.410 |
Why?
| Pharmacy Service, Hospital | 1 | 2013 | 84 | 0.400 |
Why?
| Autoimmunity | 3 | 2013 | 818 | 0.390 |
Why?
| Autoimmune Diseases | 2 | 2013 | 392 | 0.390 |
Why?
| Clinical Protocols | 1 | 2013 | 232 | 0.390 |
Why?
| Protein Binding | 5 | 2019 | 1897 | 0.380 |
Why?
| Compensation and Redress | 1 | 2011 | 7 | 0.380 |
Why?
| National Health Programs | 1 | 2011 | 20 | 0.370 |
Why?
| B-Lymphocytes | 1 | 2016 | 772 | 0.370 |
Why?
| Influenza Vaccines | 3 | 2013 | 497 | 0.370 |
Why?
| Rats | 16 | 2015 | 4963 | 0.360 |
Why?
| Phosphatidylinositols | 6 | 1995 | 53 | 0.360 |
Why?
| Lipopolysaccharide Receptors | 1 | 2010 | 82 | 0.360 |
Why?
| Leukemia, Basophilic, Acute | 5 | 1995 | 5 | 0.350 |
Why?
| Hydroxyproline | 2 | 2023 | 22 | 0.350 |
Why?
| HLA-DR Antigens | 1 | 2010 | 220 | 0.330 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 666 | 0.330 |
Why?
| Immune Tolerance | 1 | 2011 | 328 | 0.330 |
Why?
| Chronic Disease | 8 | 2018 | 1593 | 0.330 |
Why?
| Antibodies | 1 | 2011 | 372 | 0.330 |
Why?
| Thyroid Gland | 2 | 2009 | 84 | 0.330 |
Why?
| Type C Phospholipases | 5 | 1995 | 65 | 0.320 |
Why?
| Eosinophils | 2 | 2021 | 280 | 0.310 |
Why?
| Thimerosal | 1 | 2007 | 4 | 0.300 |
Why?
| Disease Models, Animal | 7 | 2018 | 3549 | 0.290 |
Why?
| Phagocyte Bactericidal Dysfunction | 4 | 1987 | 12 | 0.280 |
Why?
| Job Syndrome | 4 | 1987 | 5 | 0.280 |
Why?
| Bone Marrow Cells | 2 | 2016 | 267 | 0.280 |
Why?
| Receptors, Fc | 4 | 1991 | 45 | 0.270 |
Why?
| HLA-D Antigens | 1 | 2006 | 34 | 0.270 |
Why?
| Leukotrienes | 1 | 2006 | 35 | 0.260 |
Why?
| RNA, Messenger | 4 | 2007 | 2558 | 0.260 |
Why?
| Respiratory Hypersensitivity | 1 | 2006 | 60 | 0.260 |
Why?
| Epitope Mapping | 2 | 2016 | 51 | 0.260 |
Why?
| Vaccination | 2 | 2011 | 1205 | 0.250 |
Why?
| Angioedema | 2 | 2010 | 16 | 0.250 |
Why?
| Cell Line | 8 | 2019 | 2640 | 0.250 |
Why?
| Isoenzymes | 2 | 2003 | 285 | 0.250 |
Why?
| Hypersensitivity | 3 | 2008 | 256 | 0.250 |
Why?
| Transcriptional Activation | 1 | 2007 | 337 | 0.240 |
Why?
| Adenosine Triphosphate | 4 | 1995 | 431 | 0.240 |
Why?
| Tumor Cells, Cultured | 8 | 2003 | 855 | 0.240 |
Why?
| Interferon-gamma | 1 | 2008 | 723 | 0.240 |
Why?
| Molecular Sequence Data | 6 | 2015 | 2791 | 0.240 |
Why?
| Down-Regulation | 2 | 2006 | 596 | 0.240 |
Why?
| Hospitalization | 1 | 2013 | 1754 | 0.230 |
Why?
| Cell Nucleus | 1 | 2007 | 554 | 0.230 |
Why?
| Anti-Bacterial Agents | 1 | 2013 | 1477 | 0.220 |
Why?
| Skin Tests | 4 | 2013 | 122 | 0.220 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2010 | 1893 | 0.220 |
Why?
| Alanine | 1 | 2023 | 104 | 0.220 |
Why?
| Anacardium | 1 | 2023 | 1 | 0.220 |
Why?
| Pistacia | 1 | 2023 | 2 | 0.220 |
Why?
| Juglans | 1 | 2023 | 7 | 0.210 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2003 | 72 | 0.210 |
Why?
| NF-kappa B | 1 | 2007 | 637 | 0.210 |
Why?
| Mice | 9 | 2022 | 14935 | 0.210 |
Why?
| Child, Preschool | 8 | 2019 | 9083 | 0.210 |
Why?
| Hypergammaglobulinemia | 3 | 1987 | 9 | 0.210 |
Why?
| Bone Marrow | 3 | 2021 | 245 | 0.200 |
Why?
| Arachidonate 5-Lipoxygenase | 2 | 2006 | 45 | 0.200 |
Why?
| Female | 22 | 2019 | 59571 | 0.200 |
Why?
| Nasal Mucosa | 1 | 2002 | 93 | 0.200 |
Why?
| Basophil Degranulation Test | 3 | 2012 | 5 | 0.200 |
Why?
| Adult | 16 | 2015 | 30604 | 0.190 |
Why?
| Detergents | 1 | 2001 | 41 | 0.190 |
Why?
| Cytological Techniques | 1 | 2001 | 23 | 0.190 |
Why?
| Middle Aged | 13 | 2015 | 26801 | 0.190 |
Why?
| Histamine | 3 | 2012 | 65 | 0.190 |
Why?
| Sesamum | 1 | 2020 | 6 | 0.180 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 3 | 1991 | 33 | 0.180 |
Why?
| Antibodies, Monoclonal | 2 | 2019 | 1270 | 0.180 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2001 | 68 | 0.180 |
Why?
| Pneumonia | 1 | 2006 | 568 | 0.180 |
Why?
| Ethnopharmacology | 1 | 2000 | 1 | 0.180 |
Why?
| Cell Membrane | 5 | 1995 | 679 | 0.180 |
Why?
| Drugs, Chinese Herbal | 1 | 2000 | 13 | 0.180 |
Why?
| Antigens | 3 | 1996 | 318 | 0.180 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 93 | 0.180 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2007 | 1134 | 0.170 |
Why?
| Phosphoenolpyruvate | 3 | 1995 | 3 | 0.170 |
Why?
| Inflammation | 3 | 2007 | 2485 | 0.170 |
Why?
| Immunoblotting | 2 | 2011 | 283 | 0.170 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2001 | 278 | 0.170 |
Why?
| Enzyme Activation | 6 | 2001 | 790 | 0.170 |
Why?
| Histocompatibility Antigens | 2 | 2013 | 100 | 0.170 |
Why?
| Monocytes | 2 | 2007 | 504 | 0.170 |
Why?
| Nonprescription Drugs | 1 | 2000 | 68 | 0.170 |
Why?
| Mycoses | 1 | 2000 | 66 | 0.170 |
Why?
| Adhesins, Escherichia coli | 1 | 1999 | 1 | 0.170 |
Why?
| Gastrointestinal Tract | 1 | 2021 | 169 | 0.160 |
Why?
| Fimbriae Proteins | 1 | 1999 | 15 | 0.160 |
Why?
| Adhesins, Bacterial | 1 | 1999 | 36 | 0.160 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 101 | 0.150 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2009 | 138 | 0.150 |
Why?
| History, 21st Century | 1 | 2018 | 161 | 0.150 |
Why?
| Awards and Prizes | 1 | 2018 | 56 | 0.150 |
Why?
| Sinusitis | 1 | 2000 | 175 | 0.150 |
Why?
| Male | 14 | 2019 | 55655 | 0.150 |
Why?
| Adolescent | 9 | 2019 | 17826 | 0.150 |
Why?
| Binding Sites | 2 | 2016 | 1176 | 0.140 |
Why?
| History, 20th Century | 1 | 2018 | 267 | 0.140 |
Why?
| Phosphocreatine | 2 | 1995 | 36 | 0.140 |
Why?
| Administration, Oral | 1 | 2019 | 731 | 0.140 |
Why?
| Biomarkers | 2 | 2018 | 3418 | 0.140 |
Why?
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1997 | 39 | 0.140 |
Why?
| Molecular Mimicry | 1 | 2017 | 35 | 0.140 |
Why?
| Skin | 1 | 2021 | 659 | 0.140 |
Why?
| Calcimycin | 1 | 1996 | 47 | 0.140 |
Why?
| Child | 10 | 2015 | 18362 | 0.140 |
Why?
| Consensus Sequence | 1 | 2016 | 70 | 0.140 |
Why?
| Cell Surface Display Techniques | 1 | 2016 | 10 | 0.140 |
Why?
| Arachidonic Acid | 1 | 1996 | 117 | 0.130 |
Why?
| Immunophenotyping | 2 | 2016 | 277 | 0.130 |
Why?
| Leukocyte Common Antigens | 1 | 2016 | 76 | 0.130 |
Why?
| Chemokine CCL2 | 1 | 2016 | 105 | 0.130 |
Why?
| Magnesium | 2 | 1993 | 145 | 0.130 |
Why?
| Bacteriophages | 1 | 2017 | 75 | 0.130 |
Why?
| Adoptive Transfer | 1 | 2016 | 198 | 0.130 |
Why?
| B-Lymphocyte Subsets | 1 | 2016 | 68 | 0.130 |
Why?
| Cytokines | 5 | 2018 | 1843 | 0.130 |
Why?
| Mice, Inbred BALB C | 3 | 2006 | 1152 | 0.120 |
Why?
| Lung Transplantation | 1 | 1997 | 246 | 0.120 |
Why?
| Chromatography, Liquid | 2 | 2023 | 348 | 0.120 |
Why?
| Influenza A Virus, H1N1 Subtype | 2 | 2013 | 139 | 0.120 |
Why?
| Protein Array Analysis | 1 | 2015 | 59 | 0.120 |
Why?
| Prostaglandin D2 | 3 | 2006 | 21 | 0.120 |
Why?
| Tryptases | 2 | 2012 | 10 | 0.120 |
Why?
| Antigens, Dermatophagoides | 1 | 2014 | 10 | 0.120 |
Why?
| gamma-Tocopherol | 1 | 2014 | 4 | 0.120 |
Why?
| Macrophages | 1 | 2001 | 1266 | 0.120 |
Why?
| Cyclooxygenase 2 | 2 | 2006 | 164 | 0.110 |
Why?
| Tandem Mass Spectrometry | 2 | 2023 | 413 | 0.110 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 2 | 2013 | 243 | 0.110 |
Why?
| Vitamin E | 1 | 2014 | 110 | 0.110 |
Why?
| Genes, fos | 1 | 1993 | 33 | 0.110 |
Why?
| Cats | 2 | 2004 | 205 | 0.110 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2006 | 590 | 0.110 |
Why?
| Cluster Analysis | 1 | 2015 | 460 | 0.110 |
Why?
| Asthma | 1 | 2006 | 2042 | 0.110 |
Why?
| Headache | 1 | 2014 | 132 | 0.100 |
Why?
| Pichia | 1 | 2012 | 19 | 0.100 |
Why?
| Proteomics | 1 | 2018 | 844 | 0.100 |
Why?
| Albumins | 2 | 2023 | 89 | 0.100 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 319 | 0.100 |
Why?
| Genetic Predisposition to Disease | 3 | 2010 | 2102 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 929 | 0.100 |
Why?
| Transfection | 2 | 2007 | 870 | 0.100 |
Why?
| Mutant Proteins | 1 | 2012 | 95 | 0.100 |
Why?
| Drug Administration Schedule | 1 | 2014 | 718 | 0.100 |
Why?
| Complex Mixtures | 1 | 2011 | 11 | 0.100 |
Why?
| Blotting, Western | 2 | 2007 | 1151 | 0.100 |
Why?
| Histamine Release | 3 | 2013 | 22 | 0.090 |
Why?
| Case-Control Studies | 1 | 2018 | 3008 | 0.090 |
Why?
| Algorithms | 2 | 2008 | 1474 | 0.090 |
Why?
| Lipopolysaccharides | 2 | 2007 | 817 | 0.090 |
Why?
| Pharmacists | 1 | 2013 | 236 | 0.090 |
Why?
| Phosphoric Diester Hydrolases | 2 | 2006 | 44 | 0.090 |
Why?
| Aged | 4 | 2015 | 19120 | 0.090 |
Why?
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 58 | 0.090 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 797 | 0.090 |
Why?
| HLA-DRB1 Chains | 1 | 2010 | 98 | 0.090 |
Why?
| Antibody Formation | 1 | 2011 | 267 | 0.090 |
Why?
| Respiratory Tract Infections | 1 | 2014 | 321 | 0.090 |
Why?
| Autoantibodies | 2 | 2009 | 1354 | 0.090 |
Why?
| Medical Records | 1 | 2010 | 154 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 1 | 2014 | 1856 | 0.080 |
Why?
| Siblings | 1 | 2010 | 223 | 0.080 |
Why?
| Young Adult | 3 | 2015 | 10476 | 0.080 |
Why?
| Clinical Trials as Topic | 1 | 2014 | 934 | 0.080 |
Why?
| Infant | 5 | 2013 | 7936 | 0.080 |
Why?
| Gene Frequency | 1 | 2010 | 481 | 0.080 |
Why?
| Chromatography, Gel | 1 | 2009 | 125 | 0.080 |
Why?
| Ovalbumin | 2 | 2006 | 162 | 0.080 |
Why?
| Histocompatibility Antigens Class II | 1 | 2010 | 353 | 0.080 |
Why?
| Molecular Weight | 1 | 2009 | 332 | 0.080 |
Why?
| Dermatitis, Allergic Contact | 1 | 2009 | 63 | 0.080 |
Why?
| Haplotypes | 1 | 2010 | 453 | 0.080 |
Why?
| Phenotype | 1 | 2016 | 2817 | 0.080 |
Why?
| Cytoplasm | 1 | 1989 | 255 | 0.080 |
Why?
| Diphenhydramine | 1 | 2008 | 30 | 0.080 |
Why?
| Escherichia coli | 1 | 2012 | 722 | 0.080 |
Why?
| Th2 Cells | 2 | 2006 | 154 | 0.080 |
Why?
| Membrane Proteins | 2 | 2005 | 1022 | 0.080 |
Why?
| Histamine H1 Antagonists | 1 | 2008 | 33 | 0.080 |
Why?
| Administration, Intranasal | 1 | 2008 | 75 | 0.080 |
Why?
| United States | 4 | 2018 | 12209 | 0.070 |
Why?
| Immunotherapy | 2 | 2009 | 475 | 0.070 |
Why?
| Epinephrine | 1 | 2008 | 167 | 0.070 |
Why?
| Interleukin-4 | 1 | 2008 | 208 | 0.070 |
Why?
| Abscess | 1 | 1987 | 72 | 0.070 |
Why?
| Lysine | 2 | 2001 | 242 | 0.070 |
Why?
| HMGB1 Protein | 1 | 2007 | 48 | 0.070 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2007 | 61 | 0.070 |
Why?
| NF-kappa B p50 Subunit | 1 | 2007 | 25 | 0.070 |
Why?
| Polysaccharides, Bacterial | 1 | 2007 | 66 | 0.070 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 73 | 0.070 |
Why?
| Immunoprecipitation | 1 | 2007 | 152 | 0.070 |
Why?
| Transcription Factor RelA | 1 | 2007 | 83 | 0.070 |
Why?
| Cyclooxygenase 1 | 1 | 2006 | 20 | 0.070 |
Why?
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 8 | 0.070 |
Why?
| Nigella sativa | 1 | 2006 | 1 | 0.070 |
Why?
| Diagnosis, Differential | 3 | 2008 | 1355 | 0.070 |
Why?
| Environmental Exposure | 2 | 2009 | 377 | 0.070 |
Why?
| Goblet Cells | 1 | 2006 | 16 | 0.070 |
Why?
| Endotoxins | 1 | 2007 | 204 | 0.070 |
Why?
| Staphylococcal Infections | 2 | 1987 | 336 | 0.070 |
Why?
| Databases, Factual | 1 | 2011 | 1125 | 0.070 |
Why?
| Pyrophosphatases | 1 | 2006 | 22 | 0.070 |
Why?
| Dermatitis, Atopic | 1 | 2009 | 307 | 0.070 |
Why?
| Serum | 1 | 2006 | 57 | 0.060 |
Why?
| Plasmids | 1 | 2007 | 345 | 0.060 |
Why?
| Cell Line, Tumor | 1 | 2012 | 2725 | 0.060 |
Why?
| Thyroiditis, Autoimmune | 1 | 2005 | 14 | 0.060 |
Why?
| Bronchial Hyperreactivity | 1 | 2006 | 95 | 0.060 |
Why?
| Alopecia Areata | 1 | 2005 | 9 | 0.060 |
Why?
| Immunochemistry | 1 | 2005 | 11 | 0.060 |
Why?
| Thyroid Hormones | 1 | 2005 | 54 | 0.060 |
Why?
| Leukocyte Count | 1 | 2006 | 292 | 0.060 |
Why?
| Haptens | 2 | 1996 | 21 | 0.060 |
Why?
| Vitiligo | 1 | 2005 | 52 | 0.060 |
Why?
| Acute Disease | 1 | 2008 | 915 | 0.060 |
Why?
| Staphylococcus aureus | 2 | 1987 | 385 | 0.060 |
Why?
| Toll-Like Receptors | 1 | 2006 | 166 | 0.060 |
Why?
| Physicians | 1 | 2013 | 772 | 0.060 |
Why?
| Biological Assay | 1 | 2005 | 113 | 0.060 |
Why?
| Protein-Tyrosine Kinases | 2 | 2001 | 399 | 0.060 |
Why?
| Antibodies, Bacterial | 1 | 1985 | 119 | 0.060 |
Why?
| Immunoglobulin A | 1 | 1985 | 171 | 0.060 |
Why?
| Sequence Alignment | 2 | 2014 | 325 | 0.060 |
Why?
| Lung | 2 | 2006 | 3593 | 0.060 |
Why?
| Vaccines | 1 | 2008 | 376 | 0.050 |
Why?
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 20 | 0.050 |
Why?
| Immunologic Techniques | 1 | 2003 | 39 | 0.050 |
Why?
| Nut Hypersensitivity | 1 | 2023 | 9 | 0.050 |
Why?
| Up-Regulation | 1 | 2006 | 812 | 0.050 |
Why?
| Severity of Illness Index | 1 | 2010 | 2542 | 0.050 |
Why?
| Antibody Specificity | 2 | 2003 | 176 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2006 | 752 | 0.050 |
Why?
| Signal Transduction | 4 | 2007 | 4524 | 0.050 |
Why?
| Promoter Regions, Genetic | 1 | 2007 | 1133 | 0.050 |
Why?
| Cell Count | 2 | 2021 | 305 | 0.050 |
Why?
| Treatment Outcome | 2 | 2014 | 9105 | 0.050 |
Why?
| Reproducibility of Results | 1 | 2009 | 2769 | 0.050 |
Why?
| Hypereosinophilic Syndrome | 1 | 2021 | 9 | 0.050 |
Why?
| Time Factors | 2 | 2011 | 6125 | 0.050 |
Why?
| MAP Kinase Kinase Kinase 3 | 1 | 2001 | 3 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 10 | 1 | 2001 | 3 | 0.050 |
Why?
| Octoxynol | 1 | 2001 | 11 | 0.050 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 2001 | 12 | 0.050 |
Why?
| Mastocytosis | 1 | 2021 | 12 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 8 | 1 | 2001 | 15 | 0.050 |
Why?
| Precipitin Tests | 1 | 2001 | 88 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase 9 | 1 | 2001 | 18 | 0.050 |
Why?
| Immune Sera | 1 | 2001 | 79 | 0.050 |
Why?
| T-Lymphocytes | 2 | 2018 | 1749 | 0.050 |
Why?
| Biopsy | 2 | 2021 | 1045 | 0.050 |
Why?
| Enzyme Stability | 1 | 2001 | 62 | 0.050 |
Why?
| Valine | 1 | 2001 | 72 | 0.050 |
Why?
| Hydrolysis | 2 | 1993 | 175 | 0.050 |
Why?
| Shock, Septic | 1 | 1983 | 185 | 0.050 |
Why?
| Bacterial Infections | 1 | 1983 | 219 | 0.050 |
Why?
| Transcription, Genetic | 1 | 2007 | 1317 | 0.050 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 144 | 0.050 |
Why?
| Exocytosis | 2 | 1993 | 89 | 0.050 |
Why?
| Serine | 1 | 2001 | 126 | 0.050 |
Why?
| Gastritis | 1 | 2021 | 84 | 0.040 |
Why?
| Leukemia | 1 | 1983 | 210 | 0.040 |
Why?
| Enteritis | 1 | 2021 | 82 | 0.040 |
Why?
| Medicine, Traditional | 1 | 2000 | 23 | 0.040 |
Why?
| Mutagenesis, Site-Directed | 1 | 2001 | 345 | 0.040 |
Why?
| Catalysis | 1 | 2001 | 292 | 0.040 |
Why?
| Radioallergosorbent Test | 1 | 2000 | 4 | 0.040 |
Why?
| Environmental Illness | 1 | 2000 | 2 | 0.040 |
Why?
| Hypersensitivity, Delayed | 1 | 2000 | 31 | 0.040 |
Why?
| Protein Domains | 1 | 2021 | 207 | 0.040 |
Why?
| Calcium | 3 | 1991 | 1104 | 0.040 |
Why?
| Growth Hormone | 1 | 1980 | 103 | 0.040 |
Why?
| Interleukin-3 | 2 | 1989 | 23 | 0.040 |
Why?
| Prevalence | 1 | 2005 | 2251 | 0.040 |
Why?
| Eosinophilia | 1 | 2021 | 186 | 0.040 |
Why?
| Mannose | 1 | 1999 | 21 | 0.040 |
Why?
| Serotonin | 1 | 2001 | 296 | 0.040 |
Why?
| Ribosomes | 1 | 1980 | 148 | 0.040 |
Why?
| Muscles | 1 | 1980 | 322 | 0.040 |
Why?
| Mice, Inbred C3H | 1 | 1999 | 242 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2003 | 1700 | 0.040 |
Why?
| Drug Prescriptions | 1 | 2000 | 239 | 0.040 |
Why?
| Surveys and Questionnaires | 1 | 2009 | 4634 | 0.040 |
Why?
| Eosinophilic Esophagitis | 1 | 2021 | 296 | 0.040 |
Why?
| Leukotriene C4 | 1 | 1996 | 12 | 0.030 |
Why?
| Phosphorylation | 1 | 2001 | 1572 | 0.030 |
Why?
| Antibody Affinity | 1 | 1996 | 52 | 0.030 |
Why?
| Polyethylene Glycols | 1 | 2001 | 560 | 0.030 |
Why?
| Latex | 1 | 1996 | 9 | 0.030 |
Why?
| Rubber | 1 | 1996 | 8 | 0.030 |
Why?
| Double-Blind Method | 3 | 2006 | 1663 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2018 | 476 | 0.030 |
Why?
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 1995 | 9 | 0.030 |
Why?
| Cell Fractionation | 2 | 1989 | 51 | 0.030 |
Why?
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1995 | 14 | 0.030 |
Why?
| Vanadates | 1 | 1995 | 13 | 0.030 |
Why?
| Oligonucleotides | 1 | 1996 | 138 | 0.030 |
Why?
| Drug Interactions | 1 | 1996 | 347 | 0.030 |
Why?
| Hydroxylation | 1 | 2014 | 29 | 0.030 |
Why?
| Cell Membrane Permeability | 1 | 1995 | 83 | 0.030 |
Why?
| Leukotriene D4 | 1 | 2014 | 1 | 0.030 |
Why?
| Cell Differentiation | 1 | 2001 | 1699 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 2 | 2004 | 76 | 0.030 |
Why?
| Recombinant Proteins | 3 | 2012 | 1233 | 0.030 |
Why?
| Receptor Aggregation | 1 | 1993 | 8 | 0.030 |
Why?
| Dinitrobenzenes | 1 | 1993 | 6 | 0.030 |
Why?
| Phosphotyrosine | 1 | 1993 | 33 | 0.030 |
Why?
| Adenosine | 1 | 1995 | 202 | 0.030 |
Why?
| Mass Vaccination | 1 | 2013 | 15 | 0.030 |
Why?
| Air Pollutants | 1 | 1996 | 244 | 0.030 |
Why?
| Tyrosine | 1 | 1993 | 216 | 0.030 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2013 | 68 | 0.030 |
Why?
| Permeability | 1 | 1993 | 148 | 0.030 |
Why?
| Leukocytes | 1 | 1974 | 277 | 0.030 |
Why?
| Receptors, Interleukin-2 | 2 | 2004 | 64 | 0.030 |
Why?
| Circular Dichroism | 1 | 2012 | 135 | 0.020 |
Why?
| Clone Cells | 1 | 2012 | 248 | 0.020 |
Why?
| Protein Kinase C | 1 | 1993 | 275 | 0.020 |
Why?
| In Vitro Techniques | 1 | 1993 | 1034 | 0.020 |
Why?
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1991 | 3 | 0.020 |
Why?
| Phosphoinositide Phospholipase C | 1 | 1991 | 4 | 0.020 |
Why?
| Phosphoproteins | 1 | 1993 | 299 | 0.020 |
Why?
| Point Mutation | 1 | 2012 | 217 | 0.020 |
Why?
| Kinetics | 1 | 2014 | 1555 | 0.020 |
Why?
| Subcellular Fractions | 1 | 1991 | 78 | 0.020 |
Why?
| DNA | 2 | 1996 | 1351 | 0.020 |
Why?
| Protein Folding | 1 | 2012 | 239 | 0.020 |
Why?
| Microscopy, Electron | 1 | 1991 | 410 | 0.020 |
Why?
| Pruritus | 1 | 2010 | 60 | 0.020 |
Why?
| Flow Cytometry | 2 | 2004 | 1087 | 0.020 |
Why?
| Energy Metabolism | 1 | 1995 | 724 | 0.020 |
Why?
| Pemphigus | 1 | 2009 | 8 | 0.020 |
Why?
| Rosette Formation | 1 | 1989 | 15 | 0.020 |
Why?
| Staphylococcal Protein A | 1 | 1989 | 9 | 0.020 |
Why?
| Psoriasis | 1 | 2009 | 74 | 0.020 |
Why?
| Thyroxine | 1 | 2009 | 58 | 0.020 |
Why?
| Extracellular Space | 1 | 1989 | 117 | 0.020 |
Why?
| Adaptive Immunity | 1 | 2009 | 157 | 0.020 |
Why?
| Immunoglobulin Fc Fragments | 1 | 1988 | 35 | 0.020 |
Why?
| Sex Factors | 1 | 2013 | 1721 | 0.020 |
Why?
| Interviews as Topic | 1 | 2010 | 583 | 0.020 |
Why?
| Vasoconstrictor Agents | 1 | 2008 | 112 | 0.020 |
Why?
| Influenza, Human | 1 | 2013 | 546 | 0.020 |
Why?
| Feasibility Studies | 1 | 2010 | 737 | 0.020 |
Why?
| Body Fluid Compartments | 1 | 1987 | 5 | 0.020 |
Why?
| Ribonucleases | 2 | 1980 | 52 | 0.020 |
Why?
| Metabolic Clearance Rate | 1 | 1987 | 104 | 0.020 |
Why?
| Dermatitis, Contact | 1 | 1987 | 23 | 0.020 |
Why?
| Psychometrics | 1 | 2010 | 607 | 0.020 |
Why?
| Rhinometry, Acoustic | 1 | 2006 | 1 | 0.020 |
Why?
| IgG Deficiency | 1 | 2006 | 8 | 0.020 |
Why?
| Postoperative Complications | 1 | 1997 | 2132 | 0.020 |
Why?
| Necrosis | 1 | 2007 | 210 | 0.020 |
Why?
| Bronchial Provocation Tests | 1 | 2006 | 53 | 0.020 |
Why?
| Interleukin-8 | 1 | 2007 | 238 | 0.020 |
Why?
| Cells, Cultured | 3 | 2007 | 3897 | 0.020 |
Why?
| Serine Endopeptidases | 1 | 2006 | 102 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2008 | 954 | 0.020 |
Why?
| Dinoprostone | 1 | 2006 | 184 | 0.020 |
Why?
| Immunoglobulin A, Secretory | 1 | 1985 | 10 | 0.020 |
Why?
| Immunoglobulin D | 1 | 1985 | 27 | 0.020 |
Why?
| Haemophilus Infections | 1 | 1985 | 28 | 0.020 |
Why?
| Granulomatous Disease, Chronic | 1 | 1985 | 60 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2006 | 441 | 0.010 |
Why?
| Immunity, Innate | 1 | 2009 | 724 | 0.010 |
Why?
| Disease Progression | 1 | 2010 | 2392 | 0.010 |
Why?
| Immunoglobulin M | 1 | 1985 | 251 | 0.010 |
Why?
| Interleukin-6 | 1 | 2007 | 676 | 0.010 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 1999 | 3248 | 0.010 |
Why?
| Infant, Newborn | 1 | 2013 | 5035 | 0.010 |
Why?
| Agranulocytosis | 1 | 1983 | 31 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2013 | 6363 | 0.010 |
Why?
| Peritonitis | 1 | 1983 | 76 | 0.010 |
Why?
| Transforming Growth Factor beta | 1 | 2004 | 449 | 0.010 |
Why?
| Hypophysectomy | 1 | 1980 | 15 | 0.010 |
Why?
| Puromycin | 1 | 1980 | 11 | 0.010 |
Why?
| Peptide Biosynthesis | 1 | 1980 | 13 | 0.010 |
Why?
| Centrifugation, Density Gradient | 1 | 1980 | 40 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2008 | 4427 | 0.010 |
Why?
| Thy-1 Antigens | 1 | 1999 | 11 | 0.010 |
Why?
| Concanavalin A | 1 | 1999 | 75 | 0.010 |
Why?
| Leucine | 1 | 1980 | 104 | 0.010 |
Why?
| CD28 Antigens | 1 | 1999 | 47 | 0.010 |
Why?
| Mitogens | 1 | 1999 | 58 | 0.010 |
Why?
| Rats, Inbred F344 | 1 | 1999 | 241 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2006 | 2324 | 0.010 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2003 | 966 | 0.010 |
Why?
| Serotonin Antagonists | 1 | 1996 | 30 | 0.010 |
Why?
| Binding, Competitive | 1 | 1996 | 194 | 0.010 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1999 | 620 | 0.010 |
Why?
| Ligands | 1 | 1996 | 565 | 0.010 |
Why?
| Photomicrography | 1 | 1974 | 7 | 0.010 |
Why?
| Aspergillus | 1 | 1974 | 16 | 0.010 |
Why?
| Nucleic Acid Denaturation | 1 | 1974 | 31 | 0.010 |
Why?
| Methods | 1 | 1974 | 58 | 0.010 |
Why?
| Deoxyribonucleases | 1 | 1974 | 21 | 0.010 |
Why?
| Spectrophotometry | 1 | 1974 | 48 | 0.010 |
Why?
| Chromatography, Ion Exchange | 1 | 1974 | 48 | 0.010 |
Why?
| Histocytochemistry | 1 | 1974 | 79 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1974 | 168 | 0.010 |
Why?
| Freezing | 1 | 1974 | 85 | 0.010 |
Why?
| Staining and Labeling | 1 | 1974 | 134 | 0.010 |
Why?
| Nucleic Acid Conformation | 1 | 1996 | 669 | 0.010 |
Why?
| DNA, Single-Stranded | 1 | 1974 | 111 | 0.010 |
Why?
| Base Sequence | 1 | 1996 | 2118 | 0.010 |
Why?
| Hot Temperature | 1 | 1974 | 304 | 0.010 |
Why?
| Pancreas | 1 | 1974 | 277 | 0.010 |
Why?
| Chromatin | 1 | 1974 | 428 | 0.010 |
Why?
| RNA | 1 | 1996 | 810 | 0.010 |
Why?
| Ethanol | 1 | 1974 | 548 | 0.010 |
Why?
| Interphase | 1 | 1989 | 32 | 0.010 |
Why?
| Peptide Hydrolases | 1 | 1989 | 106 | 0.000 |
Why?
| Cell Division | 1 | 1989 | 759 | 0.000 |
Why?
| Extracellular Matrix | 1 | 1989 | 436 | 0.000 |
Why?
|
|
Dreskin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) Derived automatically from this person's publications. _
Co-Authors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People whose addresses are nearby this person. _
|